BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Patient Worthy - ECPv5.12.4//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Patient Worthy
X-ORIGINAL-URL:https://patientworthy.com
X-WR-CALDESC:Events for Patient Worthy
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20240310T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20241103T070000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20240302T090000
DTEND;TZID=America/Chicago:20240302T170000
DTSTAMP:20260511T054101
CREATED:20240130T151157Z
LAST-MODIFIED:20240130T151156Z
UID:3490554-1709370000-1709398800@patientworthy.com
SUMMARY:Amyloidosis Foundation's 2nd Annual Bradley Z. Naifeh Amyloidosis Conference
DESCRIPTION:2nd Annual Bradley Z. Naifeh Amyloidosis Conference\nMarch 2\, 2024 \nHouston\, TX \nPresented by the Bradley Z. Naifeh Amyloidosis Clinical Research and Treatment Program at Houston Methodist J.C. Walter Jr. Transplant Center. \nAmyloidosis is an underrecognized condition because it has historically been misconceived to be a rare disease and presents in a myriad of clinical situations in a subtle manner. Recent advances in therapeutics have made it imperative that this condition is recognized and categorized appropriately in a timely manner so that individuals can get access to appropriate care. Due to a systemic nature of amyloid\, various subspecialties are on the forefront of battling this disease. The goal of the Conference is to create a faculty panel from various disciplines to engage in the mission to promote awareness and educate attendees on Amyloidosis in a comprehensive manner. \nFor more information\, send an email to rbdunkin@houstonmethodist.org. \nTo register\, click here.\n 
URL:https://patientworthy.com/event/amyloidosis-foundations-2nd-annual-amyloidosis-conference/
LOCATION:Houston Methodist\, 6670 Bertner Ave\, Houston\, TX\, 77030\, United States
CATEGORIES:Amyloidosis
ORGANIZER;CN="Amyloidosis%20Foundation":MAILTO:info@amyloidosis.org
END:VEVENT
END:VCALENDAR